Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Return on Sales (2021 - 2022)

Historic Return on Sales for Immuneering (IMRX) over the last 4 years, with Q3 2023 value amounting to 115883.27%.

  • Immuneering's Return on Sales fell 1155454600.0% to 115883.27% in Q3 2023 from the same period last year, while for Sep 2023 it was 115883.27%, marking a year-over-year decrease of 1157879600.0%. This contributed to the annual value of 159.37% for FY2022, which is 1432500.0% down from last year.
  • As of Q3 2023, Immuneering's Return on Sales stood at 115883.27%, which was down 1155454600.0% from 1355.0% recorded in Q2 2023.
  • Immuneering's Return on Sales' 5-year high stood at 6.44% during Q3 2020, with a 5-year trough of 115883.27% in Q3 2023.
  • For the 4-year period, Immuneering's Return on Sales averaged around 10562.62%, with its median value being 63.76% (2021).
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -46100bps in 2021, then crashed by -1155454600bps in 2023.
  • Quarter analysis of 4 years shows Immuneering's Return on Sales stood at 8.77% in 2020, then plummeted by -560bps to 57.88% in 2021, then crashed by -51047bps to 29601.84% in 2022, then plummeted by -291bps to 115883.27% in 2023.
  • Its Return on Sales was 115883.27% in Q3 2023, compared to 1355.0% in Q2 2023 and 388.62% in Q1 2023.